{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:25:25Z","timestamp":1794349525248,"version":"4.9.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007028","name":"Leona M and Harry B Helmsley Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010311","name":"Guts UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010311","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"National Institute for Health Research Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018063","name":"Bowel Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.eclinm.2025.103644","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T02:26:06Z","timestamp":1763432766000},"page":"103644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A large-scale comparison of clinical outcomes to IBD therapies in White and South Asian ethnicities"],"prefix":"10.1016","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0229-8528","authenticated-orcid":false,"given":"Sharmili","family":"Balarajah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5271-9672","authenticated-orcid":false,"given":"Laura","family":"Martinez-Gili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6300-3100","authenticated-orcid":false,"given":"Benjamin H.","family":"Mullish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0149-6530","authenticated-orcid":false,"given":"Robert W.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia V.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian R.","family":"Marchesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles","family":"Parkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.","family":"Orchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy C.","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horace R.T.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.eclinm.2025.103644_bib1","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N Engl J Med"},{"issue":"9317","key":"10.1016\/j.eclinm.2025.103644_bib2","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103644_bib3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S2468-1253(22)00427-7","article-title":"Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial","volume":"8","author":"Feagan","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103644_bib5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.cgh.2017.05.047","article-title":"Ethnicity influences phenotype and outcomes in inflammatory bowel disease: a systematic review and meta-analysis of population-based studies","volume":"16","author":"Shi","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103644_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjae186","article-title":"Diverse phenotypes, consistent treatment: a study of 30,997 South Asian and White IBD patients using the UK IBD BioResource","volume":"19","author":"Balarajah","year":"2025","journal-title":"J Crohns Colitis"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103644_bib7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/17512433.2021.1900729","article-title":"Prevalence of polymorphisms in thiopurine metabolism and association with adverse outcomes: a South Asian region-specific systematic review and meta-analysis","volume":"14","author":"Jena","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103644_bib8","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1007\/s10620-019-05907-w","article-title":"UK patients of Bangladeshi descent with Crohn's Disease respond less well to TNF antagonists than Caucasian patients","volume":"65","author":"Gadhok","year":"2020","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103644_bib9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3390\/jcm13020319","article-title":"Racial disparities in Infliximab efficacy for ulcerative colitis: evidence synthesis and effect modification assessment","volume":"13","author":"Bonovas","year":"2024","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103644_bib10","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/ibd\/izac161","article-title":"Racial difference in efficacy of golimumab in ulcerative colitis","volume":"29","author":"Greywoode","year":"2023","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"10.1016\/j.eclinm.2025.103644_bib11","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1136\/gutjnl-2019-318835","article-title":"IBD BioResource: an open-access platform of 25 000 patients to accelerate research in Crohn's and Colitis","volume":"68","author":"Parkes","year":"2019","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103644_bib12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/gutjnl-2019-320185","article-title":"Thiopurine monotherapy is effective in ulcerative colitis but significantly less so in Crohn's disease: long-term outcomes for 11 928 patients in the UK inflammatory bowel disease bioresource","volume":"70","author":"Stournaras","year":"2021","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103644_bib13","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/ecco-jcc\/jjad203","article-title":"Biologic therapy for inflammatory bowel disease: Real-world comparative effectiveness and impact of drug sequencing in 13,222 patients within the UK IBD BioResource","volume":"18","author":"Kapizioni","year":"2024","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.eclinm.2025.103644_bib15","series-title":"R: a language and environment for statistical computing","year":"2023"},{"key":"10.1016\/j.eclinm.2025.103644_bib16","series-title":"Package \u2018WeightIt\u2019","author":"Greifer","year":"2019"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103644_bib17","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/EDE.0000000000001644","article-title":"Using balancing weights to target the treatment effect on the treated when overlap is poor","volume":"34","author":"Ben-Michael","year":"2023","journal-title":"Epidemiology"},{"issue":"521","key":"10.1016\/j.eclinm.2025.103644_bib18","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/01621459.2016.1260466","article-title":"Balancing covariates via propensity Score weighting","volume":"113","author":"Li","year":"2018","journal-title":"J Am Stat Assoc"},{"issue":"30","key":"10.1016\/j.eclinm.2025.103644_bib19","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.1002\/sim.7084","article-title":"Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis","volume":"35","author":"Austin","year":"2016","journal-title":"Stat Med"},{"issue":"10","key":"10.1016\/j.eclinm.2025.103644_bib20","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/sim.9681","article-title":"A comparison of different methods to adjust survival curves for confounders","volume":"42","author":"Denz","year":"2023","journal-title":"Stat Med"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103644_bib21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/gut.31.3.329","article-title":"Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study","volume":"31","author":"Leijonmarck","year":"1990","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.eclinm.2025.103644_bib22","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41575-020-0354-0","article-title":"Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease","volume":"17","author":"Goodman","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103644_bib23","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/ecco-jcc\/jjaa139","article-title":"Smoking May reduce the effectiveness of Anti-TNF therapies to induce clinical response and remission in Crohn's disease: a systematic review and meta-analysis","volume":"15","author":"Lee","year":"2020","journal-title":"J Crohns Colitis"},{"issue":"10 Suppl","key":"10.1016\/j.eclinm.2025.103644_bib24","first-page":"1","article-title":"Racial and ethnic differences in response to medicines: towards individualized pharmaceutical treatment","volume":"94","author":"Burroughs","year":"2002","journal-title":"J Natl Med Assoc"},{"issue":"12","key":"10.1016\/j.eclinm.2025.103644_bib25","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1093\/ecco-jcc\/jjad107","article-title":"Prevalence of NUDT15 genetic variants and incidence of thiopurine-induced leukopenia in inflammatory bowel disease: a systematic review and meta-analysis","volume":"17","author":"Yu","year":"2023","journal-title":"J Crohns Colitis"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103644_bib26","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/ecco-jcc\/jjv138","article-title":"Renal involvement in inflammatory bowel diseases","volume":"10","author":"Corica","year":"2016","journal-title":"J Crohns Colitis"},{"issue":"10","key":"10.1016\/j.eclinm.2025.103644_bib27","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/ng.3093","article-title":"HLA-DQA1\u2013HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants","volume":"46","author":"Heap","year":"2014","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.eclinm.2025.103644_bib28","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1007\/s10620-019-05720-5","article-title":"Thiopurine therapy in patients with inflammatory bowel disease: a focus on metabolism and pharmacogenetics","volume":"64","author":"Chang","year":"2019","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103644_bib29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/apt.16656","article-title":"Systematic review: the association between the gut microbiota and medical therapies in inflammatory bowel disease","volume":"55","author":"Radhakrishnan","year":"2022","journal-title":"Aliment Pharmacol Ther"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025005784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025005784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:39:52Z","timestamp":1794346792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537025005784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":27,"alternative-id":["S2589537025005784"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103644","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A large-scale comparison of clinical outcomes to IBD therapies in White and South Asian ethnicities","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103644"}}